People with epilepsy and intellectual disability
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Epilepsy is common in individuals with intellectual disability (ID), increasing with ID severity. This population faces complex health issues, necessitating advanced treatments beyond standard care.
Area Of Science
- Neurology
- Intellectual Disability Research
- Epilepsy Management
Background
- High prevalence of epilepsy in individuals with intellectual disability (ID), escalating with ID severity.
- Increased risk of seizure complications, physical impairments, and psychiatric comorbidities in people with epilepsy and ID.
- Intellectual disability is linked to drug-resistant epilepsy, often requiring polytherapy with associated adverse events.
Purpose Of The Study
- To highlight the complex health challenges faced by individuals with epilepsy and ID.
- To underscore the need for alternative and advanced treatment strategies.
- To emphasize the multifactorial nature of behavioral disorders and the complexities in care management.
Main Methods
- Review of existing literature on epilepsy in intellectual disability.
- Analysis of associated comorbidities and treatment challenges.
- Exploration of alternative therapeutic approaches.
Main Results
- Epilepsy prevalence and severity correlate with intellectual disability.
- Individuals with ID and epilepsy experience significant complications and comorbidities.
- Drug-resistant epilepsy is common, complicating treatment and increasing polytherapy use.
Conclusions
- Care for individuals with epilepsy and ID is complex, leading to social dependency and functional impairment.
- Alternative treatments like ketogenic diet, neurosurgery, and neuromodulation are crucial for intractable epilepsy.
- Addressing behavioral disorders, family burden, and care transitions is essential for comprehensive management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Focal aware seizures: In these seizures, the person remains conscious...
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...